For: | Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Mepolizumab induced palmoplantar psoriasis: A case report. World J Clin Cases 2023; 11(26): 6154-6158 [PMID: 37731552 DOI: 10.12998/wjcc.v11.i26.6154] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6154.htm |
Number | Citing Articles |
1 |
|
2 |
Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Amy B.W. LaMothe, Zamir Latif, Ann M. Lynch, Joseph Sidoti. . Side Effects of Drugs Annual 2024; 46: 189 doi: 10.1016/bs.seda.2024.09.001
|
3 |
Gauthier Coussement, Julien Catherine, Florence Roufosse. Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program. Journal of Leukocyte Biology 2024; 116(5): 1021 doi: 10.1093/jleuko/qiae152
|
4 |
Lichen Li, Dean J. Naisbitt, Yonghu Sun, Furen Zhang. Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions. Clinical & Experimental Allergy 2024; doi: 10.1111/cea.14583
|